| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |